BOSTON, May 21, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (Aktis or the Company), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including...

You have strategic business objectives. We have the network and expertise to help you realize your goals. We assemble a team that works closely with you to develop a customized investment solution.
Together, we can design a tailored investment approach to support corporate or family office initiatives, market expansion objectives, business development strategies, or any other focused business goals you have in mind.